Complementary assets, strategic alliances, and the incumbent’s advantage: an empirical study of industry and firm effects in the biopharmaceutical industry
Research Policy
2001
- DOI
- 10.1016/s0048-7333(00)00142-6
- Volume
- 30 (8)
- Pages
- 1235-1251
- Language
- en
- Export
- BibTeX
- Sources
- crossref